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Preface 
 
The 2nd International Conference on New Techniques in Pharmaceutical, Biomedical and 
Analytical Research (ICPBAR 2006), took place in Sanur Paradise Plasa Hotel, Denpasar Bali 
Indonesia on 21 – 23 August 2006. This conference, the second series after the first one held 
in Kuala Lumpur, Malaysia in 2005, is the only one conference focused on all aspects related 
to pharmaceutical, biomedical and analytical research. 
 
This proceeding contains papers that have been presented at the ICPBAR 2006 as plenary 
lectures, keynote, oral and poster presentations. About 100 participants attended the 
conference, with 8 plenary lectures, 22 oral and 24 poster presentations. The proceeding of 
ICPBAR 2006 has been published in electronic form as *.pdf file for simple and easy 
publication and to avoid heavy book of proceeding. We hope that this publication can be 
easily read, handled and transferred to other form. Furthermore, this paperless proceeding can 
be fruitful for all participants of the conference.  
 
My sincerely thanks go to all the members of Scientific Committee for their valuable help in 
the review of the submitted papers, and also to the authors for their collaborative attitude. A 
special mention must go to Tri Kuncoro, our Conference Secretary, who has put in a terrific 
amount of effort not only in general conference matter but also in the assembly of the papers 
for this proceeding. Finally, I congratulate the authors of all papers for producing the new and 
novel idea for research on pharmaceutical, biomedical and analytical developments, which are 
currently emerging fields of research in South East Asia, particularly in Indonesia.  
 
 
Jember,  August 2006 
 
B. Kuswandi 
Editor 
ICPBAR 2006 Proceeding 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
International Conference on New Technique in Pharmaceutical,  
Biomedical & Analytical Research 2006 
August, 21-23, 2006 Bali, Indonesia 
 
       iii 
Table of Content 
 
 
 
I             Preface                                                                                                                          i 
  
  
II           Content                                                                                                                         ii  
 
 
Artificial Intelligence: Genetic Algorithm and VLSI 
 Prof. K.R. Kashwan 1 
  
Design of Controlled-Release Pectinate-Chitosonium Matrix Using Microwave Technology 
 Wong Tin Wui *, Nurjaya Sumiran  10 
 
Improving Dissolution Rate of Rutin By Rutin-PEG 6000 Solid Dispersion System  
 Christina Avanti, Monika 15 
  
Characterization of Skin Delivery Dosage Form using Microwave 
 Nor Khaizan Anuar,1 Mohd Nasir Taib,2 Wong Tin Wui,1* Deepak K. Ghodgaonkar2 20 
 
Bioactive Compounds from Erythrina variegata (Leguminosae) 
 Tati Herlina1*, Euis Julaeha1, Abdul Muis1, Unang Supratman1, Anas Subarnas2, 
Supriyatna Sutardjo2, Syafruddin3, and Hideo Hayashi4 25 
  
Bioautography of N- Hexan and Water Fractionation of Leaves of Syzygium polyanthum (Wight) 
Walp. 
 Melani*, Elisawati Wonohadi**, Dian Puspita Sari** and Kurniawan** 29 
 
Antibacterial Compound Identification of The Chloroform and Ethyl-acetate Extract of Syzygium 
polyanthum (Wight.) Walp. Leaves against Staphylococcus aureus by Bioautography 
Method 
 Elisawati Wonohadi 1, Melani 2, Christina Fatma L1 33 
 
The Development of Transdermal Piroxicam Delivery  using HPMC Matrices with PVP K-30 as a 
Penetration Enhancer. 
 Ni Luh Dewi Aryani 37 
 
The Effect of Enzyme Concentration on the Production of Cyclodextrins in Batch Process 
 1,2,3 A.M. Mimi Sakinah, 3,*Rosli Md Illias, 1A.F. Ismail, 4Osman Hassan,  1A.W Zularisam 42 
 
The Ratio of Impeller Diameter to Reactor Diameter Effect on Cyclodextrins Production Under Batch 
Process  
 1,2,3 A.M. Mimi Sakinah, 3,*Rosli Md Illias, 1A.F. Ismail, 4Osman Hassan,  1A.W Zularisam 44 
 
Katsoubushi and Water Activity in the Formulation of Sata Product  
 Rita Hayatia, Amanas Abdullaha, Mohd.Khan Ayoba, Soewarno T.Soekartob  46 
 
Effect of Chitosan on Experimentally Induced Murine Listeriosis  
 Nadarajah, K., Seh, C.C., Ahmad, I.B. and Zainal-Abidin, A.H. 50 
 
Anti-Arthritic Effects of Musa paradisiaca sapientum L in Adjuvant-Induced  Arthritic Rats 
 Endang Darmawan, Sri Mulyaningsih 54 
 
 
 
International Conference on New Technique in Pharmaceutical,  
Biomedical & Analytical Research 2006 
August, 21-23, 2006 Bali, Indonesia 
 
       iv 
Low Power Memory Design using Latched Pass-transistor Adiabatic Logic for Bio-medical and 
sensor based applications 
 Ravi Shekhar1, Achal Kathuria1, Manu Rastogi2 and N. Vinod Reddy1 59 
 
Health Effect Analysis of Ginger (Zingiber officinale Roscue) Bioactive Compounds Human 
Lymphocyte Function In  Stress Oxidative Conditions In Vitro 
 Tejasari 63 
 
Larvaside Effect of Ethanolo Extract of Myristica fragrans Houtt. Arilus Against Aedes aegypti Linn. 
Larvae 
 Sajekti Palupi1, Inez1, Sri Subekti2 67 
 
Nutrition Education and Sun Exposure Increases Vitamin D Status Among Postmenopausal Malaysian 
Women 
 Ari Istiany1,2, AR Suriah2, MY Zaitun3, WSS Chee2, YM Chan3 & MP Asmaa’ 2 70 
 
Effect Of Calcium Supplementation On Serum Calcium, Phosphorus and Magnesium Changes In 
Malay Postmenopausal Women 
 MF Fazlini1, AR Suriah1, Y Zaitun2, WSS Chee3, K Mirnalini 2, YM Chan2,O Sofiah2 & 
SP Chan4 74 
 
Effect of GCM1 from Gracilaria changii on the activation of p38 and pp38 mitogen – activated 
protein kinases (MAPKs) in CaOV-3 cells 
 Norazfa Johari and Hasidah Mohd Sidek 79 
 
Sequential Determination of Iron Species (Fe(11)/Fe(III)) Using Flow Injection Analysis 
 aZainiharyati Mohd Zain*,  bWoo Sin Yee, bWan Tat Wai and bBahruddin Saad 83 
 
Method Validation Analysis of Captropil in Human Plasma in vitro by HPLC 
 Yahdiana H, Harmita, Maryati K 88 
 
Heavy Metals Concentrations in the Sediment in Rivers and Sea Around Estuary  Rivers’s of 
Kenjeran Surabaya 
 Ririn Sumiyani* Soediatmoko Soediman* and Atiek Moesriati** 91 
 
A Simple  Fiber Optic Sensor for CO2 Measurement Utilizing Indicator Dye 
 Faiz Bukhari Mohd Suah 1*, Narlia Tajri1 and Mohd Nasir Taib2 95 
 
An Optical Biochemical Sensor for Phenolic Compounds Based on  Stcaked Films Containing 
Horseradish Peroxidase and MBTH 
 Jaafar Abdullaha, Musa Ahmada, Lee Yook Henga, Nadarajah Karuppiahb and Hamidah 
Sidekb  98 
 
Optimum Sensor-Array Selection Method for Electronic-Nose using MLR and RMSE Analysis 
 K. R. Kashwan*1 and M. Bhuyan2 101 
 
Determination of ciprofloxacin in human plasma by high performance liquid chromatography - 
fluorescence 
 Yahdiana Harahap*, Budi Prasaja**, Ega Indriati**, Windy Lusthom** 107 
 
Preliminary Study on Application of Aptamer-Modified Magnetic Beads for Thrombin Measurement 
 Siswoyo1, M. Mascini2, G. Marrazza2, and F. Lucarelli2 111 
 
Optical Reflectance Cu (II) Sensor Based on Immobilized Chrom Azurol S on  XAD 2 
 Afinidar 1, Musa Ahmad2, Lee Yook Heng2, Rita Sundari2 117 
 
 
 
 
International Conference on New Technique in Pharmaceutical,  
Biomedical & Analytical Research 2006 
August, 21-23, 2006 Bali, Indonesia 
 
       v 
Mixed Raster Contents for Medical Image Compression with Distributed Computing Technique 
 Ade Bayu Kristian 121 
 
Optical Biosensor for Uric Acid Based on Immobilised Uricase onto Poly-O-Methylaniline Film 
 B. Kuswandi, D. Hermanto A.A.I. Ratna Dewi and A.A. Gani 127 
 
Optical Urea Biosensor Based on Immobilised Enzyme onto Polyaniline Film  
 B. Kuswandi, B. Fauziyah and A. A. Gani 133 
 
Optical Fiber Biosensor Based on Immobilised Enzyme on Sol-Gel Glass for pesticides monitoring 
 A. A. Gani, C. I. Fikriyah and B. Kuswandi 138 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
International Conference on New Technique in Pharmaceutical,  
Biomedical & Analytical Research 2006 
August, 21-23, 2006 Bali, Indonesia 
  37 
The Development of Transdermal Piroxicam Using HPMC Matrices  
With PVP K-30 as a Penetration Enhancer 
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Abstract 
 
The physicochemical properties such as solubility, partition coefficient, and membrane permeability of a drug 
are required for formulating and estimating drugs absorption that pass through biological membranes. The 
research studied about solubility, partition coefficient in octanol-phosphate buffer, rabbit skin permeability and 
release from the transdermal delivery system of piroxicam with addition of 6% PVP K-30 in vitro into phosphate 
buffer solution pH 7.4 at temperature 320 ± 10C. The results showed that the solubility of piroxicam was 904.44 
± 20.92 μg/mL. The values of log IPC and APC were 1.99 ± 0.01 and 0.08 ± 0.01, respectively. The flux, 
permeability coefficient, and diffusion coefficient of the piroxicam permeation process were 2.07 x 10-4 
µg/cm2/sec, 4.96 x 10-6 cm/minute, and 4.13 x 10-8 cm2/minute, respectively. The release mechanism of 
piroxicam from transdermal delivery system was more dominant by diffusion than erosion. The fluxes of 
piroxicam release were 0,169 and 0,107 mg/cm2/minute for formulation with 2% HPMC and 4% HPMC, 
respectively.  
 
Keywords: Piroxicam, HPMC, PVP K-30, Transdermal delivery 
 
1. Introduction 
 
 Piroxicam is a nonsteriod antiinflamation drug 
(NSAID) which is often used in rheumatoid 
arthritis treatment. It is like other NSAIDs, 
piroxicam provides side effects in gastrointestinal. 
Thus, transdermal delivery system is an attractive 
option to overcome this problem. Piroxicam was 
reported that had poor skin permeability. So that 
was suggested to enhance the skin permeability 
with a penetration enhancer (1-4). 
 Skin is largest organ of the body, is composed 
of several layers: the stratum corneum (uppermost 
layer), viable epidermis, dermis and hypodermis. 
One commonly hears that the skin is too good 
barrier to permit the delivery of all but a few 
compounds. Low skin permeability originates from 
unique hierarchical structure of the stratum 
corneum. Stratum corneum consists of several 
layers of keratinocytes within which lipid bilayer 
are stacked (5-7). Hence, the attempts have been 
made to circumvent this barrier by using 
“penetration enhancer”, i.e., compounds which 
would temporarily and reversibly diminish the 
barrier function of the stratum corneum and make 
possible percutaneous absorption of drugs. 
Penetration enhancer should be nontoxic, 
pharmacological inert, nonirritant, non-alergenic, 
reversible, pharmaceutical stable, cosmetically 
acceptable (8-11). 
 One of the penetration enhancer is polyvinyl-
pyrrolidone (PVP). PVP is the pyrrolidones, which 
the primary site of action is most likely the polar 
route, and there intrinsic humectant activity, is a 
significant factor in their little doubt that hydration 
of the skin, owing to their effectiveness (12)  
 The skin permeability of drugs with certain 
polarity depends on the skin/vehicle partition 
coefficient. It is not easy to measure skin/vehicle 
partition coefficient of permeant. Hence, it is 
usually used partition coefficient octanol/water 
instead. Partition coefficient octanol/water is 
lipophilicity parameter of drugs. It is an important 
factor to determine permeability of drug across 
biological membranes (13, 14). Beside the partition 
coefficient, the skin permeability of drugs depends 
on solubility of drugs also (14, 15).  
Beside the physicochemical properties, the 
release rate of the drugs is also required for 
formulating and estimating drug absorption pass 
through biological membranes. The release rate of 
the drugs is influenced by the dosage form (16). 
The research studied about solubility, partition 
coefficient in octanol-phosphate buffer, rabbit skin 
permeability and the release from the transdermal 
delivery system of piroxicam with addition of  6% 
PVP K-30 in vitro. In this study, the transdermal 
delivery system developed by using hydroxilpropil-
metilcellulose (HPMC). 
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2. Materials and Methods 
 
2.1. Materials 
Piroxicam (obtained from PT Coronet Crown. 
Surabaya, Indonesia), HPMC K-100M (Colorcon), 
PVP K-30 (The Dow Chemical Company), NaH-
2PO4, Na2HPO4, NaOH, octanol, ethanol, methanol 
(E Merck), rabbit skin, cellophane membrane, all 
solvent and reagent were analytical grade.  
 
2.2. Methods 
 
2.2.1. Solubility Study 
Piroxicam solubility study was done by 
addition of excess of the drug into the phosphate 
buffer pH 7.4 solution containing 6% PVP K-30. 
The mixture was allowed to equilibrate using 
shaker at 32 ±1oC for 24 hours. After that, the 
suspension was filtered, suitably diluted, and 
analyzed spectrophotometrically at 354 nm 
 
2.2.2. Partition Coefficient Study 
Piroxicam partition coefficient study was done by 
adding of piroxicam 10 mg/L with addition of 6% PVP 
K-30 into octanol saturated phosphate buffer pH 7.4. 
Using incubator shaker water bath this mixture was 
agitated with 200 rpm at 32±1oC for 24 hours and then 
centrifuged. After that, the phases were separated. The 
water phase was suitably diluted and analyzed 
spectrophotometrically at 354 nm. The partition 
coefficients were calculated with the following equations: 
 
IPC = [ ][ ]wHA
HA 0  = [ ]wHAC0               (1) 
 Cw = [HA]w  + [A¯]w    ( 2) 
 
 APC = [ ]
[ ] [ ]ww
0
A +HA
HA  = 
Cw
C 0                    (3) 
where IPC is the intrinsic partition coefficient, [HA]o 
is the concentration of unionized drug in octanol 
phase, [HA]w is the concentration of unionized drug in 
phosphate buffer phase,  [A-]w is the concentration of 
ionized drug in phosphate buffer phase, Co is the 
concentration of drug in octanol phase, Cw is the 
concentration of drug in water phase, APC is the 
apparent partition coefficient. 
 
2.2.3. In vitro Permeation Study 
An in vitro permeation study was carried out by 
using a diffusion cell modified from Higuchi diffusion 
cell (Figure 1). The diffusion cells were maintained at 
32±1oC by the electrical water bath. The rabbit skin was 
mounted on the diffusion cell with the stratum corneum 
side facing the donor compartment and the dermal side 
facing the receptor compartment. The rabbit skin 
samples were placed into isotonic phosphate buffer 
solution pH 7.4 and kept in the refrigerator at 40 C for 
24 hours prior to the experiment. Piroxicam solution 
20µg/mL in phosphate buffer pH 7.4 with addition of 
6% PVP K-30 was placed in the donor compartment. 
The phosphate buffer pH 7.4 was then introduced into 
the receptor compartment. The capacity of donor 
compartment and receptor compartment were 125 mL, 
respectively. The samples from the receptor were taken 
at predetermined time intervals and immediately 
replaced by an equal volume of fresh buffer solution. 
The samples were analyzed spectrophotometrically at 
354 nm. The permeability parameters were calculated 
from the penetration data with the following equations: 
 
Sdt 
dM = J = Kp Cd    (4) 
 
M/S = Kp Cd t      (5) 
 
KP =    
h
P D      (6) 
 
where M is the amount of piroxicam 
penetrated, S is the area of rabbit skin membrane 
(4.9cm2), KP is the permeability coefficient, Cd is 
the piroxicam concentration in donor compartment, 
t is time, D is the diffusion coefficient, P is the 
partition coefficient octanol/ phosphate buffer  
 
 
 
Figure 1. Diffusion cell assembly (side by side model) 
 
2.2.4. Formulation 
The quantities used for preparing the gel 
formulations are listed in Table 1.  
 
Table 1. Formulations of Piroxicam Gel 
Ingredient Formulation I Formulation II 
Piroxicam 
HPMC 
PVP K-30 
NaOH 10% solution 
Ethanol 
Nipagin 
Aqua ad 
1% 
2% 
6% 
1% 
5% 
0.2% 
100% 
1% 
4% 
6% 
1% 
5% 
0.2% 
100% 
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The Formulations were prepared as follows: 
HPMC was dissolved into hot water and stirred 
constantly. Piroxicam was dissolved into ethanol 
and NaOH solution. PVP K-30 was dissolved into 
water and added into Piroxicam solution. The 
mixture was added into the HPMC gel base and 
stirred until homogeneous. 
 
2.2.3. In Vitro Drug Release Study 
An in vitro drug release study was carried out 
by using dissolution testing apparatus 5 USP 
(paddle over disk). The disk was filled with the gel 
(2 g) and placed into the receptor medium 
containing 900 mL of phosphate buffer pH 7.4 
solutions. The cellophane was mounted on the disk. 
The apparatus was run at 50 rpm, and temperature 
was maintained at 32 ±1oC. The samples from the 
receptor were taken at predetermined time intervals 
and immediately replaced by an equal volume of 
fresh buffer solution. The samples were analyzed 
spectrophoto-metrically at 354 nm. 
 
3. Results and Discussion 
 
 The solubility of piroxicam with addition of 
6% PVP K-30 was 904.44±20.92 µg/mL. The 
dissociation constant (pKa) of Piroxicam is 5.5 (1). 
Thus, base on Handerson-Haselbalch equation, 
percentage of ionization of piroxicam in phosphate 
buffer pH 7.4 was 98.75% or almost 100%. In the 
last study was reported that solubility of piroxicam 
in phosphate buffer pH 7.4 at temperature 32 ±1o C 
was 856.06 ± 46.72 µg/mL (17). Increasing 
solubility of piroxicam with addition of PVP K-30 
might be due to forming of complex Piroxicam-
PVP which was more soluble in water. Solubility of 
piroxicam has an important role in the permeability. 
The maximum flux depends on drug solubility in 
vehicle, it is increases with growing water solubility 
in the case of hydrophilic gel (14). 
Partition coefficient could be determined as 
apparent partition coefficient (APC) or intrinsic 
partition coefficient (IPC). The values of log APC 
and IPC of piroxicam with addition of 6% PVP K-
30 were 1.99 ± 0.01 and 0.08 ± 0.01, respectively. 
In the last study was reported that APC and IPC of 
piroxicam in octanol/phosphate buffer pH 7.4 at 
temperature 32 ±1o C were 1,97 and 0,0637, 
respectively (17). The partition coefficient is the 
lipophilcity parameter of the drugs. Thus, the 
lipophilicity of piroxicam was not influenced in 
addition of PVP.  
The diffusion process of piroxicam across 
rabbit skin was analyzed from the diffusion profile 
(Figure 2). The Regression equation of the profile was 
Y = 0.0124 X + 5.2181 with correlation coefficient 
(r) = 0.957. The regression equation was obtained 
using the last 5 data. The regression line was linear, 
so it represented that the transport process of the 
drug from the donor compartment into the receptor 
compartment followed zero order kinetics. Thus, 
the diffusion parameter could be determined using 
Ficks Equation. The diffusion parameters of 
piroxicam diffusion process with addition of PVP 
K-30 are listed in Table 2. 
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Figure 2. Plot of cumulative amount of piroxicam 
penetrated across rabbit skin versus time.  
 
Table 2.  The diffusion parameter of diffusion process of 
piroxicam with addition of PVP K-30 
Parameter Values of 
Parameter 
Permeability coefficient (cm/minute) 
Diffusion coefficient (cm2/minute) 
Flux (µg/cm2/seconds) 
4.96 x 10-6 
4.13 x 10-8 
2.07 x 10-4 
 
 Permeability is a diffusion parameter which 
determines capability of solute across membrane. 
Beside nature of the membrane, the permeability of 
solute also depends on the solute movement rate to 
achieve the membrane surface.  
 Diffusion coefficient is diffusion parameter which 
relate to membrane area. The diffusion coefficient of 
piroxicam with addition of 6% PVP K-30 was 
determined with assuming that the partition coefficient 
membrane-water as same as the partition coefficient 
octanol-phosphate buffer solution pH 7.4. 
 Release mechanisms of drugs from dosage form 
could be by diffusion or erosion. The release 
mechanisms by diffusion follow Higuchi equation; it 
could be analyzed from the amount of piroxicam 
release from the HPMC gels as a function of square 
root of time. These profiles are showed in Figure 3. 
The release by erosion mechanism was analyzed from 
the amount of piroxicam release from the HPMC gels 
as a function of time. These profiles are showed in 
Figure 4. Regression equation of the release profiles in 
Figure 3 and 4 are showed in Table 3 and 4.  
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Table 3. Regression equation of release profiles of  
formulation I 
Formulation I Release 
Mechanism Regression equation r  
Diffusion Y = 0.169X - 0,198 0.993 
Erosion Y = 0.009X + 0.529 0.975 
 
 
Table 4. Regression  equation of release profiles of  
formulation II 
Formulation II Release 
Mechanism Regression equation r  
Diffusion Y = 0.107X - 0,213 0.994 
Erosion Y = 0.005X + 0.252 0.965 
 
The values of coefficient correlation (r) of the regression 
equation of release by diffusion for formulation I and II 
are greater than by erosion. Thus, the release mechanisms 
of the gels were more dominant by diffusion than 
erosion.  
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Figure 3. Plot of amount of piroxicam released from 
HPMC gels versus square root of time.      
Note: (●) formulation I and (■) formulation II 
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Figure 4. Plot of amount of piroxicam released from 
HPMC gels versus time. Note: (●) formulation 
I and (■) formulation II 
 The release mechanisms of piroxicam from the 
HPMC gels with 6% PVP K-30 were analyzed 
from the Figure 3 and 4. Slope of the regression 
equation which is listed in table 3 and 4 represented 
of the flux release of piroxicam from the gels. The 
flux release of piroxicam from the gels formulation 
I and II by diffusion were 0.169 and 0.107 
mg/cm2/minute, respectively. The concentration of 
HPMC in formulation II was higher than in 
formulation I, thus the viscosity of formulation II 
was higher than formulation I. Increasing in 
viscosity caused decreasing in diffusity, thus the 
flux released of formulation II lower than 
formulation I. 
 
4. Conclusion 
 
 The solubility of piroxicam increased with 
addition of 6% PVP K-30. The solubility of 
piroxicam with addition of 6% PVP K-30 was 
904.44 ± 20.92 μg/mL The flux, permeability 
coefficient, and diffusion coefficient of piroxicam 
with addition of 6% PVP K-30 across rabbit skin 
were 2.07x10-4µg/cm2/sec, 4.96x10-6 cm/minute, 
4.13x10-8 cm2/minute, respectively. The flux release 
of formulation I, which contained 2% HPMC and 
6% PVP K-30, was higher than formulation II, 
which contained 4% HPMC and 6% PVP K-30. 
The viscosity of the formulations influenced the 
piroxicam release from the gels.  
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